carbamates has been researched along with Mast-Cell Sarcoma in 1 studies
Mast-Cell Sarcoma: A unifocal malignant tumor that consists of atypical pathological MAST CELLS without systemic involvement. It causes local destructive growth in organs other than in skin or bone marrow.
| Excerpt | Relevance | Reference |
|---|---|---|
| " A short term LF 08--0299 treatment at optimal dosage protected more than 75% of recipient mice from lethal GVHD induced either across minor antigens alone or the full H2 barrier." | 1.29 | Prevention of lethal graft-versus-host disease following allogeneic bone marrow transplantation in mice by short course administration of LF 08-0299. ( Annat, J; Bruley-Rosset, M; Churaqui, E; Dutartre, P, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Annat, J | 1 |
| Churaqui, E | 1 |
| Dutartre, P | 1 |
| Bruley-Rosset, M | 1 |
1 other study available for carbamates and Mast-Cell Sarcoma
| Article | Year |
|---|---|
Prevention of lethal graft-versus-host disease following allogeneic bone marrow transplantation in mice by short course administration of LF 08-0299.
Topics: Adoptive Transfer; Animals; Bone Marrow Transplantation; Carbamates; Drug Administration Schedule; D | 1996 |